Published in J Acquir Immune Defic Syndr Hum Retrovirol on March 01, 1996
Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health (2001) 4.57
Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States. J Urban Health (2006) 2.42
Prevalence and duration of hepatitis C among injection drug users in San Francisco, Calif. Am J Public Health (2001) 2.02
Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS. Neurosci Biobehav Rev (2008) 1.52
Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent. J Clin Invest (2002) 1.46
Prevention of HIV infection among injection drug users in resource-limited settings. Clin Infect Dis (2010) 1.28
Syringe availability as HIV prevention: a review of modalities. J Urban Health (2000) 1.02
Prescription drug misuse and risk behaviors among young injection drug users. J Psychoactive Drugs (2013) 0.97
Telephone survey of Alaskan pharmacists' nonprescription needle-selling practices. J Urban Health (2000) 0.86
Risk factors for hepatitis B in an outbreak of hepatitis B and D among injection drug users. J Urban Health (2005) 0.82
Religiosity and HIV-related drug risk behavior: a multidimensional assessment of individuals from communities with high rates of drug use. J Relig Health (2014) 0.80
Needle stick injuries in the community. Paediatr Child Health (2008) 0.75
Methodological problems in AIDS behavioral research: influences on measurement error and participation bias in studies of sexual behavior. Psychol Bull (1990) 11.25
HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science (1999) 8.11
The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA (2000) 7.65
Intersecting epidemics--crack cocaine use and HIV infection among inner-city young adults. Multicenter Crack Cocaine and HIV Infection Study Team. N Engl J Med (1994) 6.01
Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA (2001) 5.52
Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health (1996) 5.45
Sex differences in HIV-1 viral load and progression to AIDS. Lancet (1998) 5.24
Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med (2001) 4.98
Self-reported antiretroviral therapy in injection drug users. JAMA (1998) 4.75
Sex differences in risk factors for hiv seroconversion among injection drug users: a 10-year perspective. Arch Intern Med (2001) 4.68
Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection. Hepatology (1999) 4.11
Correlates of hepatitis C virus infections among injection drug users. Medicine (Baltimore) (1995) 3.85
Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users. JAMA (1992) 3.81
Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 3.68
Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science (1998) 3.60
Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users. AIDS (2001) 3.56
Molecular and geographic patterns of tuberculosis transmission after 15 years of directly observed therapy. JAMA (1998) 3.07
Changes in T-lymphocyte subsets in intravenous drug users with HIV-1 infection. JAMA (1992) 3.07
HIV risk-related sex behaviors among injection drug users, crack smokers, and injection drug users who smoke crack. Am J Public Health (1993) 3.05
Neuropathological and neuropsychological changes in "normal" aging: evidence for preclinical Alzheimer disease in cognitively normal individuals. J Neuropathol Exp Neurol (1998) 2.92
Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J Immunol (1996) 2.86
Outcomes of care in birth centers. The National Birth Center Study. N Engl J Med (1989) 2.85
Voluntary testing for human immunodeficiency virus (HIV) in a prison population with a high prevalence of HIV. Am J Epidemiol (1994) 2.81
Factors associated with adolescent initiation of injection drug use. Public Health Rep (2001) 2.73
Initial plasma HIV-1 RNA levels and progression to AIDS in women and men. N Engl J Med (2001) 2.68
Correlates of HIV infection among young adult short-term injection drug users. AIDS (2000) 2.63
Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. J Clin Microbiol (1997) 2.55
Sex related HIV risk behaviors: differential risks among injection drug users, crack smokers, and injection drug users who smoke crack. Drug Alcohol Depend (2000) 2.51
Using social network analysis to study patterns of drug use among urban drug users at high risk for HIV/AIDS. Drug Alcohol Depend (1995) 2.51
Seroreactivity to hepatitis E virus in areas where the disease is not endemic. J Clin Microbiol (1997) 2.48
Racial differences in HLA class II associations with hepatitis C virus outcomes. J Infect Dis (2001) 2.47
Antibody responses to Haemophilus influenzae type B vaccines in men with human immunodeficiency virus infection. N Engl J Med (1991) 2.46
HIV seropositivity of needles from shooting galleries in south Florida. Am J Public Health (1990) 2.37
Inactivation of human immunodeficiency virus-1 at short time intervals using undiluted bleach. J Acquir Immune Defic Syndr (1993) 2.36
Design and baseline participant characteristics of the Human Immunodeficiency Virus Epidemiology Research (HER) Study: a prospective cohort study of human immunodeficiency virus infection in US women. Am J Epidemiol (1997) 2.32
Longitudinal patterns of drug injection behavior in the ALIVE Study cohort,1988-2000: description and determinants. Am J Epidemiol (2003) 2.32
People and places: behavioral settings and personal network characteristics as correlates of needle sharing. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 2.26
Vitamin A deficiency and wasting as predictors of mortality in human immunodeficiency virus-infected injection drug users. J Infect Dis (1995) 2.25
Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. Proc Natl Acad Sci U S A (2000) 2.24
Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City. Am J Public Health (2001) 2.21
Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex. N Engl J Med (1985) 2.20
Temporal trends of incident human immunodeficiency virus infection in a cohort of injecting drug users in Baltimore, Md. Arch Intern Med (1995) 2.08
Explaining racial disparities in incidence of and survival from out-of-hospital cardiac arrest. Am J Epidemiol (2007) 2.07
The long-term outcome of a personal network-oriented HIV prevention intervention for injection drug users: the SAFE Study. Am J Community Psychol (1996) 2.07
Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data. Ann Intern Med (2001) 2.05
Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. Addiction (1993) 2.01
Transmission of HIV-1 within a statewide prison system. AIDS (1988) 2.00
Occupational risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infections among funeral service practitioners in Maryland. Infect Control Hosp Epidemiol (1995) 1.95
The association between cigarette smoking and drug abuse in the United States. J Addict Dis (2000) 1.92
Epidemiology of hepatitis B virus infections among injecting drug users: seroprevalence, risk factors, and viral interactions. Epidemiol Rev (1994) 1.87
Compliance with universal precautions among health care workers at three regional hospitals. Am J Infect Control (1995) 1.83
Using the drug abuse screening test (DAST-10) to analyze health services utilization and cost for substance users in a community-based setting. Subst Use Misuse (2001) 1.81
Gender differences in the initiation of injection drug use among young adults. J Urban Health (2000) 1.78
The consistency of self-reported HIV risk behavior among injection drug users. Am J Public Health (1994) 1.78
Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities. J Neurosci (1996) 1.78
Antibody to hepatitis C virus among cardiac surgery patients, homosexual men, and intravenous drug users in Baltimore, Maryland. Am J Epidemiol (1991) 1.76
Chronic illicit drug use, health services utilization and the cost of medical care. Soc Sci Med (2000) 1.76
Discarded needles do not increase soon after the opening of a needle exchange program. Am J Epidemiol (1997) 1.76
Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's disease. Acta Neurol Scand (2009) 1.75
Syphilis serology in human immunodeficiency virus infection: evidence for false-negative fluorescent treponemal testing. J Infect Dis (1997) 1.74
Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline. Proc Natl Acad Sci U S A (1998) 1.72
Access to antiretroviral treatment among French HIV infected injection drug users: the influence of continued drug use. MANIF 2000 Study Group. J Epidemiol Community Health (1999) 1.71
My place, your place, and no place: behavior settings as a risk factor for HIV-related injection practices of drug users in Baltimore, Maryland. Am J Community Psychol (1994) 1.71
Correlates of enrollment in methadone maintenance treatment programs differ by HIV-serostatus. AIDS (2000) 1.70
HTLV-I/II seropositivity and death from AIDS among HIV-1 seropositive intravenous drug users. Lancet (1990) 1.70
Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women. HIV Epidemiology Research Study Group. Clin Infect Dis (1999) 1.69
Utilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus. Am J Public Health (1991) 1.68
Risk factors for shooting gallery use and cessation among intravenous drug users. Am J Public Health (1991) 1.66
Crack cocaine smoking and oral sores in three inner-city neighborhoods. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.65
Collaboration among community members, local health service providers, and researchers in an urban research center in Harlem, New York. Public Health Rep (2002) 1.65
Seroepidemiology of hepatitis B virus in a population of injecting drug users. Association with drug injection patterns. Am J Epidemiol (1995) 1.65
TNF-alpha opens a paracellular route for HIV-1 invasion across the blood-brain barrier. Mol Med (1997) 1.65
Early penetration of the blood-brain-barrier by HIV. Neurology (1988) 1.62
The relationship between risk networks' patterns of crack cocaine and alcohol consumption and HIV-related sexual behaviors among adult injection drug users: a prospective study. Drug Alcohol Depend (1996) 1.59
Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease. Arch Intern Med (1996) 1.59
Bacterial pneumonia in adult populations with human immunodeficiency virus (HIV) infection. Am J Epidemiol (1993) 1.59
Cervical neoplasia and repeated positivity of human papillomavirus infection in human immunodeficiency virus-seropositive and -seronegative women. Am J Epidemiol (2000) 1.57
Prevalence and incidence of HIV among incarcerated and reincarcerated women in Rhode Island. J Acquir Immune Defic Syndr (1999) 1.57
Access to medical care and service utilization among injection drug users with HIV/AIDS. Drug Alcohol Depend (2001) 1.57
Immunocytochemical localization of the dopamine transporter in human brain. J Comp Neurol (1999) 1.55
Comparison of a tuberculin interferon-gamma assay with the tuberculin skin test in high-risk adults: effect of human immunodeficiency virus infection. J Infect Dis (1997) 1.54
Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users. J Infect Dis (1996) 1.53
Frequency and type of electrocardiographic abnormalities in cocaine abusers (electrocardiogram in cocaine abuse). Am J Cardiol (1994) 1.53
Measurement of HIV risk behaviors among intravenous drug users. Br J Addict (1992) 1.53
High risk of HIV-related mortality is associated with selenium deficiency. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.53
Selective risk taking among needle exchange participants: implications for supplemental interventions. Am J Public Health (2001) 1.52
New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1. Am J Epidemiol (1991) 1.52
The trading of sex for drugs or money and HIV seropositivity among female intravenous drug users. Am J Public Health (1994) 1.52